Literature DB >> 18458650

Effects of routine infant vaccination with the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization with streptococcus pneumoniae in children in Calgary, Canada.

James D Kellner1, David Scheifele, Otto G Vanderkooi, Judy Macdonald, Deirdre L Church, Gregory J Tyrrell.   

Abstract

BACKGROUND: All Streptococcus pneumoniae disease is preceded by nasopharyngeal (NP) colonization. We studied the impact of 7-valent pneumococcal conjugate vaccine (PCV7) on colonization in healthy children.
METHODS: Routine PCV7 vaccination began in Alberta in 2002. Six point prevalence surveys were conducted from 2003 to 2005, in 7 community health centers in Calgary where children had their routine vaccinations. A questionnaire was administered and a single NP swab was obtained for culture. Serotyping was performed on all S. pneumoniae isolates.
RESULTS: There were 3398 children with complete data, 1307, 1225, and 866 in 12-month, 18-month, and 4-6 year groups, respectively. None had received PCV7 in survey 1. From survey 2 onwards, 92-98% of 12-month-olds had 3 or more doses of PCV7, and from survey 3 onwards, 95-99% of 18-month-olds had 3 or more doses. By survey 6, only 4% of 4-6 year olds had 3 or more doses. The overall S. pneumoniae colonization rate was 20%. In all age groups, including unvaccinated 4-6 year olds, there were significant declines in PCV7 serotypes, and increases in non-PCV7 serotypes. The largest increases were serotypes 6A, 15C, and 11A. Multivariate analysis found that factors including age, siblings, daycare attendance, episodes of otitis media, and antibiotic use affected S. pneumoniae colonization but only PCV7 vaccination was associated with decreased PCV7 serotype colonization and increased non-PCV7 colonization.
CONCLUSIONS: Routine PCV7 vaccination has led to significant changes in the predominant S. pneumoniae serotypes found in NP colonization in both vaccinated and unvaccinated children, indicating both a direct and herd effect.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18458650     DOI: 10.1097/INF.0b013e3181658c5c

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  20 in total

1.  Pneumococcal nasopharyngeal carriage following reduced doses of a 7-valent pneumococcal conjugate vaccine and a 23-valent pneumococcal polysaccharide vaccine booster.

Authors:  F M Russell; J R Carapetis; C Satzke; L Tikoduadua; L Waqatakirewa; R Chandra; A Seduadua; S Oftadeh; Y B Cheung; G L Gilbert; E K Mulholland
Journal:  Clin Vaccine Immunol       Date:  2010-10-13

2.  A new pneumococcal serotype, 11E, has a variably inactivated wcjE gene.

Authors:  Juan J Calix; Moon H Nahm
Journal:  J Infect Dis       Date:  2010-07-01       Impact factor: 5.226

3.  Pneumococcal carriage at age 2 months is associated with growth deficits at age 6 months among infants in South India.

Authors:  Christian L Coles; Lakshmi Rahmathullah; Reba Kanungo; Joanne Katz; Debora Sandiford; Sheela Devi; R D Thulasiraj; James M Tielsch
Journal:  J Nutr       Date:  2012-04-25       Impact factor: 4.798

4.  Impact of a pneumococcal conjugate vaccination program on carriage among children in Norway.

Authors:  Didrik F Vestrheim; E Arne Høiby; Ingeborg S Aaberge; Dominique A Caugant
Journal:  Clin Vaccine Immunol       Date:  2010-01-27

5.  Spectrum of pneumococcal serotype 11A variants results from incomplete loss of capsule O-acetylation.

Authors:  Juan J Calix; Allison M Brady; Victor Y Du; Jamil S Saad; Moon H Nahm
Journal:  J Clin Microbiol       Date:  2013-12-18       Impact factor: 5.948

6.  Pneumococcal nasopharyngeal carriage in children <5 years of age visiting the pediatric emergency room in relation to PCV7 and PCV13 introduction in southern Israel.

Authors:  Shalom Ben-Shimol; Noga Givon-Lavi; David Greenberg; Ron Dagan
Journal:  Hum Vaccin Immunother       Date:  2016       Impact factor: 3.452

7.  Elucidation of structural and antigenic properties of pneumococcal serotype 11A, 11B, 11C, and 11F polysaccharide capsules.

Authors:  Juan J Calix; Moon H Nahm; Edward R Zartler
Journal:  J Bacteriol       Date:  2011-07-29       Impact factor: 3.490

8.  Antimicrobial susceptibility of invasive and lower respiratory tract isolates of Streptococcus pneumoniae, 1998 to 2007.

Authors:  Otto G Vanderkooi; Athena McConnell; Deirdre L Church; James D Kellner
Journal:  Can J Infect Dis Med Microbiol       Date:  2009       Impact factor: 2.471

9.  Update on the success of the pneumococcal conjugate vaccine.

Authors:  Jd Kellner
Journal:  Paediatr Child Health       Date:  2011-04       Impact factor: 2.253

10.  Streptococcus pneumoniae meningitis in Alberta pre- and postintroduction of the 7-valent pneumococcal conjugate vaccine.

Authors:  Jennie Johnstone; Gregory J Tyrrell; Thomas J Marrie; Sipi Garg; James D Kellner
Journal:  Can J Infect Dis Med Microbiol       Date:  2011       Impact factor: 2.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.